Importantly, tumor-specific CD8+ T cells readily identified in TDLNs are generally of an early dysfunctional phenotype and express intermediate levels of PD-1 and the chemokine receptor CXCR5 and high levels of T-cell factor 1 (TCF-1) [52,54]. This evidence concerns the gene CD8A and neoplasm.